Anoat Therapeutics

Paris, France

Anoat Therapeutics develops an innovative, disease-modifying approach in Cystic Fibrosis.

$2.2M raised

Jun 2023

Seed

Biopharma Biotechnology Pharmaceutical Product Research Therapeutics

Top Investors

AdBio partners

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Anoat Therapeutics

How much funding has Anoat Therapeutics raised?

Anoat Therapeutics has raised $2.2M in total funding. The most recent round was Seed. The last funding was announced in June 2023.

Who are Anoat Therapeutics's investors?

Anoat Therapeutics's investors include AdBio partners.

Where is Anoat Therapeutics headquartered?

Anoat Therapeutics is headquartered in Paris, France.

What does Anoat Therapeutics do?

Anoat Therapeutics develops an innovative, disease-modifying approach in Cystic Fibrosis.

What stage is Anoat Therapeutics at?

Anoat Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 19, 2023.

MLA

"Anoat Therapeutics — Funding & Investors." VCBacked, June 19, 2023, https://www.vcbacked.co/company/anoat-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2023). Anoat Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/anoat-therapeutics

Wikipedia (cite web)

{{cite web |title=Anoat Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/anoat-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 19, 2023.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.